541
Participants
Start Date
April 30, 2006
Primary Completion Date
June 30, 2015
Study Completion Date
June 30, 2015
physiologic testing
Markers of thyroid function including thyroid stimulating hormone (TSH), Free thyroxine (free T4) and Thyroid peroxidase antibody (TPO Ab). These will be performed at baseline, in 12 months and again 24 months after enrollment. All thyroid function marker assays will be performed by LabCorp.
fatigue assessment and management
Fatigue Symptoms Inventory (FSI) survey
management of therapy complications
If baseline testing results suggest hyperthyroidism or hypothyroidism, the enrolling center will give test results to participants for follow-up with their primary healthcare provider. Participants with hypothyroidism, who are not started on thyroid hormone, will continue on study, given the TSH level is below 10. Those with hypothyroidism who have treatment initiated will not continue on study. Participants who develop hypothyroidism during the study will not continue on-study if replacement therapy is initiated or if the TSH level is 10 or higher. Work up the next control nominated by the patient or contact the patient for the name of another control
MBCCOP - Our Lady of Mercy Comprehensive Cancer Center, The Bronx
Our Lady of Mercy Medical Center Comprehensive Cancer Center, The Bronx
Forsyth Regional Cancer Center at Forsyth Medical Center, Winston-Salem
Southeastern Medical Oncology Center - Goldsboro, Goldsboro
Southeastern Medical Oncology Center - Wilson, Wilson
Rutherford Internal Medicine Associates, PA, Forest City
Pardee Memorial Hospital, Hendersonville
Mission Hospitals - Memorial Campus, Asheville
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center, Spartanburg
AnMed Cancer Center, Anderson
Northeast Georgia Cancer Care, LLC - Medical Oncology, Athens
Cancer Centers of Central Florida, PA, Leesburg
William Beaumont Hospital - Royal Oak Campus, Royal Oak
William Beaumont Hospital - Troy Campus, Troy
MeritCare Bemidji, Bemidji
CCOP - MeritCare Hospital, Fargo
Roger Maris Cancer Center at MeritCare Hospital, Fargo
Saint Anthony's Hospital at Saint Anthony's Health Center, Alton
Good Samaritan Regional Health Center, Mount Vernon
CCOP - St. Louis-Cape Girardeau, St Louis
David C. Pratt Cancer Center at St. John's Mercy, St Louis
Southeast Cancer Center, Cape Girardeau
Saint Francis Medical Center, Cape Girardeau
CCOP - Cancer Research for the Ozarks, Springfield
Hulston Cancer Center at Cox Medical Center South, Springfield
MBCCOP - LSU Health Sciences Center, New Orleans
CCOP - Scott and White Hospital, Temple
Scott and White Cancer Institute, Temple
McKee Medical Center, Loveland
CCOP - Western Regional, Arizona, Phoenix
North Colorado Medical Center, Greeley
H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa
Medical College of Georgia Cancer Center, Augusta
MBCCOP - Medical College of Georgia Cancer Center, Augusta
Feist-Weiller Cancer Center at Louisiana State University Health Sciences, Shreveport
CCOP - Beaumont, Royal Oak
St. John's Regional Health Center, Springfield
Newark Beth Israel Medical Center, Newark
CCOP - Southeast Cancer Control Consortium, Goldsboro
Moses Cone Regional Cancer Center at Wesley Long Community Hospital, Greensboro
Iredell Memorial Hospital, Statesville
National Cancer Institute (NCI)
NIH
University of South Florida
OTHER